Trulicity Market Size to Reach USD 15.30 Billion by 2035 with Strong Demand for Metabolic Treatments | SNS Insider
Austin, May 04, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Trulicity Market size was valued at USD 7.03 Billion in 2025 and is expected to reach USD 15.30 Billion by 2035, growing at a CAGR of 8.16% during the forecast period 2026–2035.
The global Trulicity market is experiencing exponential growth due to the rise in cases of type 2 diabetes and obesity in different parts of the globe. The rising use of GLP-1 receptor agonists, wider uses in cardiovascular diseases, and technological developments in biologics-based drug delivery systems are some of the major forces behind the expansion of this market.
Trulicity Market Size and Forecast:
Get a Sample Report of Trulicity Market Growth Strategy @ https://www.snsinsider.com/sample-request/10030
U.S. Trulicity Market Insights
The U.S. Trulicity Market was valued at USD 2.39 billion in 2025 and is expected to reach USD 4.87 billion by 2035, growing at a CAGR of 8.22% over 2026–2035.
The US dominates the Trulicity market across the globe, attributed to the country’s high number of patients suffering from diabetes and obesity, use of GLP-1 drugs, advanced health care facilities, and favorable reimbursement schemes. Another factor driving the market is the increasing tendency among doctors to prescribe biological drugs and advancements in pen injector technology.
Rising Prevalence of Diabetes and Obesity to Drive Market Growth Globally
The global Trulicity market is primarily driven by increasing prevalence of type 2 diabetes and obesity. As metabolic diseases are recognized more and more commonly in clinical practice, the use of GLP-1 receptor agonists for glycemic control and cardiovascular disease risk reduction is gaining momentum.
The increasing use of Trulicity in conditions besides diabetes, supported by innovation in dosage forms, and also the sector prospects are a big factor to build the growing Trulicity marketplace. Growing safety, efficacy and compliance will contribute to its increased adoption in hospitals, retail pharmacies and at home.
Trulicity Market Segmentation Analysis:
By Therapeutic Application
On the basis of primary indication, Type 2 Diabetes led the global diabetes devices market in terms of revenue share with forecast revenue of US$61.97 billion in 2025 reaching a share of 59.38%. The overweight and weight loss patients are expected to be the fast-growing segments with a CAGR of approximately 9.68% in terms of revenue during the forecast period, which can be attributed to growing obesity prevalence globally as well as high adoption rates of GLP-1 drugs.
By Patient Demographics
The 18–64 years segment led the global market in terms of revenue share despite being relatively low compared to people over 65, accounting for around 54.69% in 2025; due to a high volume with diabetes and obesity within this age group. High-risk populations with obesity and diabetes will be the fastest growing subpopulations (CAGR 10.93% up to 2035).
By Distribution Channel
By 2025, hospital pharmacies accounted for largest managed distribution share across the revenue model at nearly 29.87%, attributed to higher number of prescriptions and organized treatment guidelines. So far as the distribution channel is concerned, online pharmacies are estimated to lead with a CAGR of roughly 9.60% over the progression period, attributable to increasing healthcare digitalization.
By Dosage & Formulation
Due to effectiveness and safety advantages, the 1.5 mg once weekly pen occupied ~24.56% of revenue share in 2025. The once weekly pen with a 4.5 mg dose will see the fastest CAGR over the forecast period, projected at roughly 9.70%, due to improved weight management and glycemic control outcomes.
Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/10030
Trulicity Market Regional Insights:
North America appears to be the dominant region and accounted for nearly 40.14% revenue share in 2025, owing to the established healthcare system coupled with high disease incidence rate & well-structured reimbursement landscape It is well positioned given the widely adopted GLP-1 based medicines and advances in biologics.
The most effective growth in the Asia Pacific area is due to a growing quantity of diabetic subjects, developing healthcare up healing facilities, and multiplied awareness about metabolic problems in rising nations which includes China and India with an anticipated CAGR of around 9.23% for the duration of 2018-2024.
Likewise, Europe is a huge market with robust healthcare infrastructure and favorable reimbursement trends. On the other hand, Latin America and Middle East & Africa continuing to reap growth due to improved appeal of healthcare deliverables along with chronic disease management programs.
Major Players Analysis Listed in the Trulicity Market Report:
Trulicity Market Recent Developments:
Purchase Comprehensive Trulicity Market Report – Single User PDF @ https://www.snsinsider.com/checkout/10030
Exclusive Sections of the Report (The USPs):
Trulicity Market Report Scope:
Demand for Industry Analysis: Our Comprehensive Report Trulicity Market @ https://www.snsinsider.com/reports/trulicity-market-10030
Other Related Trending Report:
GLP-1 Receptor Agonist Market
Type 2 Diabetes Market
Continuous Glucose Monitoring Market
Blood Glucose Monitoring Device Market
BRIC Diabetes Care Devices Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.